You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 74 No. 3, September 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Experimental Fungal Keratitis

ELIOT L. BERSON, MD; GEORGE S. KOBAYASHI, PhD; RICHARD B. OGLESBY, MD

Arch Ophthalmol. 1965;74(3):403-411.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Several excellent reviews10,11,26,39,42 and case reports4,5,21,24,27 have emphasized the difficulty in treatment of mycotic keratitis and the aggravating effects of some antibiotics20,33,41 and steroids1,4,20,28,40 on these infections. The various forms of chemotherapy have included amphotericin B with debridement,4,5,13 30% sodium sulfacetamide solution by iontophoresis,13 1:1,000 Merthiolate ophthalmic ointment,13 nystatin topically,9,31 local cycloheximide,23 and oral sodium iodide with local 0.125% copper sulfate and tincture of iodine.2,6 Poor intraocular penetration29 and local toxicity1 of the suggested drugs have hampered interpretation of chemotherapy. Physical measures suggested for treatment have included ultraviolet phototherapy,7 thermophore,2 and excision with keratoplasty.42 Human clinical experience has been difficult to evaluate because the stage of the disease at the time of treatment has varied and the fungus has differed from case to case. The number of cases reported by any single study has been . . . [Full Text PDF of this Article]


Author Affiliations

St. Louis

From the Department of Ophthalmology and the Oscar Johnson Institute, Washington University School of Medicine. Department of Ophthalmology (Dr. Berson and Dr. Oglesby); Department of Internal Medicine, Division of Dermatology (Dr. Kobayashi).


Footnotes

Submitted for publication April 24, 1965.

Reprint requests to Department of Ophthalmology, Washington University School of Medicine, 660 S Euclid Ave, St. Louis, Mo 63110 (Dr. Berson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.